Supplementary Methods from <i>NRAS</i> Status Determines Sensitivity to SHP2 Inhibitor Combination Therapies Targeting the RAS–MAPK Pathway in Neuroblastoma

Abstract

&lt;p&gt;Includes supplementary methodology for cell culture, chemicals, plasmids and transfections, GTP pulldown and immunoblotting analyses, and antibodies used for study.&lt;/p&gt;